The cardioprotective effect of S. africana caerulea/Blue Sage in ischaemia and reperfusion induced oxidative stress
Frontiers in Pharmacology · 25.09.2023 · 14
DOI: 10.3389/fphar.2023.1254561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.09.2023. Verfasst von Ruduwaan Salie und 3 weiteren Autor:innen. Beteiligte Einrichtung: South African Medical Research Council, Biomedical Research and Innovation Platform, Cape Town, Western Cape, South Africa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Since antiquity, alternative herbal remedies, such as S. africana caerulea /Blue Sage (BLS) water infusion extract (WIE) has been used by traditional healers, for the effective treatment of various chronic inflammatory disorders associated with reduced cellular antioxidant defense mechanisms and free radical cellular damage. In the heart, ischaemia—reperfusion (I/R) induced oxidative stress becomes an early crucial event in the pathogenesis of ischaemia—reperfusion injury (I/RI) and subsequent heart failure. Purpose/Aim: To investigate whether BLS WIE treatment during ischaemia and/or reperfusion may be cardioprotective. Study design: Isolated perfused rat hearts were exposed to 35 min regional ischaemia (RI) and 60 min reperfusion. The BLS WIE was applied: i) for the last 10 min of RI (PerT) or ii) from onset of reperfusion (PostT) or iii) both (PerT) + (PostT).
Methods
Endpoints were functional recovery and infarct size (IS). In another set of experiments, left ventricles were freeze-clamped after RI and 10 min reperfusion for detection of total and phosphorylated p-ERK p44/p42, p-Akt, p-p38-MAPK, p-JNK, Nrf-2, NF-kB, Bax, Bcl-2, Caspase-3, and PGC-1α by Western blot analysis.
Results
BLS (PostT) significantly increased ERK p44, p-Akt, Nrf-2, and Bcl-2 levels; significantly decreased p-p38-MAPK as well as p-JNK p46 phosphorylation; did not affect Bax levels and significantly decreased Bax/Bcl-2 ratios. This was associated with significantly reduced Caspase-3 levels and increased PGC-1α phosphorylation, particlarly when BLS WIE was administered as PostT.
Conclusion
The administration of polyphenol-rich BLS WIE at different stages of ischaemia and/or reperfusion, activate/inhibit several signaling events simultaneously and mediate cardioprotection in a multitarget manner.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- South African Medical Research Council, Biomedical Research and Innovation Platform, Cape Town, Western Cape, South Africa.
- Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.
Zitieren
APA
Salie, R., Lopes, J., Kotze, L., & van Aarde, R. (2023). The cardioprotective effect of S. africana caerulea/Blue Sage in ischaemia and reperfusion induced oxidative stress. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1254561
Vancouver
Salie R, Lopes J, Kotze L, van Aarde R. The cardioprotective effect of S. africana caerulea/Blue Sage in ischaemia and reperfusion induced oxidative stress. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1254561
BibTeX
@article{Salie2023,
author = {Salie, Ruduwaan and Lopes, John and Kotze, Leon and van Aarde, Ruzayda},
title = {The cardioprotective effect of S. africana caerulea/Blue Sage in ischaemia and reperfusion induced oxidative stress},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1254561}
}
EUVIMED